日本高清视频色欧www

Vaccines 2020: World Market Analysis, Players, Trends

Vaccines 2020: World Market Analysis, Players, Trends

This report examines the market for these vaccines used to prevent various types of disease, and provides market modeling by disease. It focuses on commercialized vaccines and developmental vaccines for diseases that are already vaccine-preventable, with a discussion of selected emerging vaccines for diseases that are not currently vaccine-preventable, such as addiction and malaria. The report also discusses trends and looks at what vaccine companies have done and are planning. It also covers the COVID-19 vaccine market landscape, development progress and estimated market opportunity as of October 2020.

Because of the large number of deadly diseases that have been virtually eliminated through the proliferation of effective vaccines, vaccination is generally viewed as one of the greatest public health achievements during the 20th century. As a result of widespread public vaccination, vaccine-preventable diseases and their resulting deaths are now rare in the developed nations and declining worldwide. Immunizations have eradicated smallpox; eliminated poliomyelitis in the Americas; and controlled measles, rubella, tetanus, diphtheria,

As part of its offering this report involves the following data points and others:

  • Influenza Vaccine Global Market, 2020-2025
  • US, European, and ROW Vaccine Markets by Type (Hepatitis, Combinations, Meningitis, Pneumococcal, Rotavirus, Influenza, HPV, Shingles, Others)
  • Major Manufacturers’ Shares of the Global Vaccine Market, 2020
  • Global Market for Pediatric Preventive Vaccines by Type (Hepatitis, Pediatric Routine (HiB, MMR, Combinations, Polio, Varicella), Meningitis, Pneumococcal Disease, Rotavirus, HPV, Others) 2020–2025
  • Global Market for Adult Preventive Vaccines by Type (Hepatitis, HPV, Pneumococcal, Tetanus and combinations, Shingles, Travel & Other) 2020–2025
  • Selected Pediatric Vaccines in Development, 2020
  • Selected Adult Vaccines in Development, 2020
  • COVID-19 Vaccine Developments
  • COVID-19 Vaccine Potential Market Estimate, High Case and Low Case
  • Development of new vaccines is ongoing. Generally speaking, vaccine clinical development in the world’s major markets follows a similar pathway as drugs and other biologics. A sponsor who wishes to begin clinical trials with a vaccine must first obtain permission to conduct clinical studies. In the U.S., this requires the submission of an Investigational New Drug (IND) application to the FDA.
“mitigating against growth will be continuing concerns about vaccine safety and refusal to immunize.”

The IND describes the vaccine, its method of manufacture, and quality control tests for release. Also included is information about the vaccine’s safety and ability to elicit a protective immune response (immunogenicity) in animal testing as well as the proposed clinical protocol for studies in humans. Kalorama’s report tracks development of vaccines, including those for COVID-19.

The report as well reviews the history and lines of business, strategic alliances, vaccine products, and financial information of market leaders such as GlaxoSmithKline, Merck, Pfizer, and Sanofi Pasteur.

COMPANY COVERAGE

Companies Covered in the Report Include:
ADVAXIS
BAVARIAN NORDIC, A/S
BHARAT BIOTECH INTERNATIONAL
CSL LIMITED/SEQIRUS
EMERGENT BIOSOLUTIONS
GLAXOSMITHKLINE
HAWAII BIOTECH
IMMUNE RESPONSE BIOPHARMA
INOVIO PHARMACEUTICALS
JOHNSON & JOHNSON/CRUCELL/JANSSEN
MEDICAGO
MERCK & CO
MITSUBISHI TANABE PHARMA CORPORATION
MODERNA
NOVAVAX
PFIZER
SANOFI PASTEUR
SERUM INSTITUTE
SOLIGENIX
TAKEDA PHARMACEUTICAL CO
VALNEVA SE


  • Executive Summary
    • The Global Vaccines Industry
    • Scope and Methodology
    • Market Estimates and Forecasts
      • Table Global Vaccine Market, 2020 – 2025, $M
  • Introduction to Vaccines
    • Introduction
      • Table Global Morbidity of Vaccine Preventable Diseases in 1990 vs. 2019
      • Table CDC Infographic: Global Impact of Vaccines in Reducing Vaccine-Preventable Disease Morbidity and Mortality
    • A Brief History: The Development of Vaccines
    • The Human Immune System
    • Vaccine Mechanism of Action
    • Types of Vaccines
      • Attenuated (Weakened) Live Viruses
        • Table Attenuated Virus Production
      • Killed (Inactivated) Viruses
      • Toxoid Vaccines
      • Genetically Engineered/Modified Vaccines
    • Vaccine Approval Process
      • Table VAERS Table of Reportable Events Following Vaccination
    • World Health Organization Prequalified Vaccines
      • Table WHO Prequalified BCG Vaccines
      • Table WHO Prequalified Cholera Vaccines
      • Table WHO Prequalified Diphtheria-Tetanus Vaccines
      • Table WHO Prequalified Diphtheria-Tetanus-Pertussis Vaccines
      • Table WHO Prequalified Diphtheria-Tetanus-Pertussis-Hemophilus influenzae type b Vaccines
      • Table WHO Prequalified Diphtheria-Tetanus-Pertussis and Hepatitis B Vaccines
      • Table WHO Prequalified Diphtheria-Tetanus-Pertussis-Hepatitis B-Hemophilus influenzae type b Vaccines
      • Table WHO Prequalified Hemophilus influenzae type b Vaccines
      • Table WHO Prequalified Hepatitis A Vaccines
      • Table WHO Prequalified Hepatitis B Vaccines
      • Table WHO Prequalified Human Papillomavirus Vaccines
      • Table WHO Prequalified Influenza Vaccines
      • Table WHO Prequalified Japanese Encephalitis Vaccines
      • Table WHO Prequalified Measles Vaccines
      • Table WHO Prequalified Measles and Rubella Vaccines
      • Table WHO Prequalified Measles, Mumps and Rubella Vaccines
      • Table WHO Prequalified Meningococcal A Vaccines
      • Table WHO Prequalified Pneumococcal Vaccines
      • Table WHO Prequalified Polio Vaccines
      • Table WHO Prequalified Rabies Vaccines
      • Table WHO Prequalified Rotavirus Vaccines
      • Table WHO Prequalified Rubella Vaccines
      • Table WHO Prequalified Tetanus Toxoid Vaccines
      • Table WHO Prequalified Typhoid Vaccines
      • Table WHO Prequalified Varicella Vaccine
      • Table WHO Prequalified Yellow Fever Vaccines
    • Pandemics
      • HIN1 Pandemic of 2009/2010
      • Coronavirus Pandemic
        • Table COVID-19 Per Capita Doses Ordered by Country (through October 2020)
        • Table COVID-19 Vaccine Candidates: Government Presales
      • Ebola Epidemic 2014-2016
      • Manufacturing Incentives
      • Synthetic Vaccines
    • Artificial Intelligence Development
  • Pediatric Preventative Vaccines
    • Introduction
      • Table Global Child Immunization Rates for Vaccines Recommended by the WHO, 2019
    • Childhood Immunization in the United States
      • Childhood Immunization Rates
      • Challenges to the Vaccine Delivery System
      • Recommended Childhood Immunization Schedule
        • Table CDC Recommended Immunization Schedule: Birth to 15 Months
        • Table CDC Recommended Immunization Schedule: 18 Months to 18 Years
      • State Immunization Recommendations
        • Table Polar Graph on State School Vaccination Exemptions Law, United States
      • United Nations Initiatives
    • Pediatric Vaccine Markets
      • Table Global Market for Pediatric Preventive Vaccines by Type (Hepatitis, Pediatric Routine (HiB, MMR, Combinations, Polio, Varicella), Meningitis, Pneumococcal Disease, Rotavirus, Influenza, HPV, Others) 2020–2025, in $ Millions
      • Table Global Market for Pediatric Preventive Vaccines by Type (Hepatitis, Pediatric Routine (HiB, MMR, Combinations, Polio, Varicella), Meningitis, Pneumococcal Disease, Rotavirus, Influenza, HPV, Others) 2020–2025 (%)
      • Table Market Share of Pediatric Preventive Vaccines by Type (Hepatitis, Pediatric Routine (HiB, MMR, Combinations, Polio, Varicella), Meningitis, Pneumococcal Disease, Rotavirus, Influenza, HPV, Others) 2020 (%)
    • Pediatric Vaccines in Development
      • Table Selected Pediatric Vaccines in Development, 2020
    • Competitive Summary
      • Table Major Manufacturers' Shares of the Global Pediatric Preventative Vaccine Market, 2020 (%, $ Millions)
      • Table 2020 Global Pediatric Preventative Vaccines Market Share, by Leading Competitors (%)
  • Adult Preventative Vaccines
    • Introduction
    • Recommended Adult Immunizations
      • Table CDC Recommended Immunization Schedule: Adults, 19 years and over
    • Global Influenza Surveillance Program
      • U.S. Surveillance
        • Table U.S. Influenza Vaccine Effectiveness, 2004 – 2020 (%)
      • WHO International Health Regulations
      • Influenza
        • Table U.S. Flu Season Severity from 2008 to 2018
        • Table WHO Pandemic Classification Schedule
    • Adult Preventive Vaccine Markets
      • Table Global Market for Adult Preventive Vaccines by Type (Hepatitis, HPV, Influenza, Pneumococcal, Tetanus and combinations, Shingles, Travel & Other) 2020–2025, in $ Millions
      • Table Global Market for Adult Preventive Vaccines by Type (Hepatitis, HPV, Influenza, Pneumococcal, Tetanus and combinations, Shingles, Travel & Other) 2020–2025 (%)
      • Table Market Share of Adult Preventive Vaccines by Type (Hepatitis, HPV, Influenza, Pneumococcal, Tetanus and combinations, Shingles, Travel & Other) 2020 (%)
      • Influenza Vaccine Market: Generating 28% of Total Adult Vaccine Sales
        • Table U.S. Seasonal Influenza Vaccination by Age Group and Season, 2010-2020
        • Table U.S. Seasonal Influenza Vaccination Coverage and HP 2020 Target – Total Population - Seasons 2010-2020
      • COVID-19 Market Size Estimates and Forecast
    • Adult Vaccines in Development
      • Table Selected Adult Preventive Vaccines in Development, 2020
      • COVID-19 Vaccine Development
        • Table Regional Distribution of COVID-19 Vaccine Development
        • Table COVID-19 Vaccine Development, Distribution by Vaccine Platform
        • Table Select Vaccines in Development for COVID-19 – Phase I through Phase III
    • Competitive Summary
      • Table Major Manufacturers' Shares of the Global Adult Preventative Vaccine Market, 2020 (%, $ Millions)
      • Table 2020 Global Adult Preventative Vaccines Market Share, by Leading Competitors (%)
  • Total Vaccines Market
    • Trends Driving the Vaccines Market
      • Table Sales Growth of Vaccines vs. Pharmaceuticals, 2015-2025
    • Market Size and Forecast
      • Table Total Global Market for Preventive Vaccines by Type, 2020–2025, in $ Millions
      • Table Total World Market for Vaccines by Type, 2015-2024 (Pediatric, Adult) ($ Millions)
      • Pediatric Vaccines
      • Adult Vaccines
        • Table Global Preventive Vaccine Market by Broad Segment (Pediatric, Adult), Trend 2015 – 2025 $millions
      • Vaccine Sales by Region
        • Table Total U.S. Market for Preventive Vaccines by Type, 2020–2025, in $ Millions
        • Table Total Europe Market for Preventive Vaccines by Type, 2020–2025, in $ Millions
        • Table Total ROW Market for Preventive Vaccines by Type, 2020–2025, in $ Millions
    • Vaccine Market Competitors
      • Table Major Manufacturers' Shares of the Global Vaccine Market, 2020 (%, $ Millions)
      • Table 2020 Global Vaccines Market Share, by Leading Competitors (%)
    • COVID-19 Vaccine Market
      • Table Global COVID-19 Vaccine Market Forecast, 2021 ($ millions)
      • Table Global COVID-19 Vaccination Rate Forecast, (United States, Europe) 2021 %
      • Table Global COVID-19 Vaccine Stockpiling and Government Contracts, Q4 2020 – 2025, Total Value ($M)
      • Table Global COVID-19 Vaccine Stockpiling and Government Contracted Dose Order Distribution based on $ Value, Q4 2020 – 2025, % by Country
    • Global Healthcare Mergers and Acquisitions
      • Table Total U.S. Healthcare M&A Deal Value, 2010–2019, in $ Billions
    • Recent Vaccine Activity by Key Players: 2020 Developments
      • GlaxoSmithKline
      • Merck & Co.
      • Pfizer
      • Sanofi
  • Company Profiles
    • Advaxis, Inc.
      • Table Advaxis Corporate Summary
      • Company Summary
      • Products
    • Bavarian Nordic, A/S
      • Table Bavarian Nordic A/S Corporate Summary
      • Company Summary
      • Products
    • Bharat Biotech International Ltd.
      • Table Bharat Biotech Corporate Summary
      • Company Summary
      • Products
    • CSL Limited/Seqirus
      • Table CSL/Seqirus Corporate Summary
      • Company Summary
      • Products
    • Emergent BioSolutions, Inc.
      • Table Emergent BioSolutions Corporate Summary
      • Company Summary
      • Products
    • GlaxoSmithKline, Inc.
      • Table GlaxoSmithKline Corporate Summary
      • Company Summary
      • Products
        • Table GSK Marketed Vaccines 2020
        • Table GSK Vaccines in Development 2020
    • Hawaii Biotech, Inc.
      • Table Hawaii Biotech Corporate Summary
      • Company Summary
      • Products
    • Immune Response Biopharma, Inc.
      • Table Immune Response Biopharma Corporate Summary
      • Company Summary
      • Products
    • Inovio Pharmaceuticals, Inc.
      • Table Inovio Corporate Summary
      • Company Summary
      • Products
    • Johnson & Johnson/Crucell/Janssen
      • Table Johnson & Johnson Corporate Summary
      • Company Summary
      • Products
    • Medicago, Inc.
      • Table Medicago Corporate Summary
      • Company Summary
      • Products
    • Merck & Co, Inc.
      • Table Merck Corporate Summary
      • Company Summary
      • Products
    • Mitsubishi Tanabe Pharma Corporation
      • Table Mitsubishi Tanabe Corporate Summary
      • Company Summary
      • Products
    • Moderna, Inc
      • Table Moderna Corporate Summary
      • Company Summary
      • Products
    • NovaVax, Inc.
      • Table NovaVax Corporate Summary
      • Company Summary
      • Products
    • Pfizer, Inc.
      • Table Pfizer Corporate Summary
      • Company Summary
      • Products
    • Sanofi Pasteur
      • Table Sanofi Pasteur Corporate Summary
      • Company Summary
      • Products
    • Serum Institute, Inc.
      • Table Serum Institute of India Corporate Summary
      • Company Summary
      • Products
    • Soligenix, Inc.
      • Table Soligenix Corporate Summary
      • Company Summary
      • Products
    • Takeda Pharmaceutical Co, Ltd.
      • Table Takeda Pharmaceutical Corporate Summary
      • Company Summary
      • Products
    • Valneva SE
      • Table Valneva Corporate Summary
      • Company Summary
      • Products

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

亚洲色情视频免费网站看v片在线a色老在线视频亚洲久久热在线视频成 人?色综合亚洲区色色琪琪www 618se con document.write (''); 亚洲色欧洲图 亚洲无线码2019 久草在线免费 日韩亚洲国产高清免费视频 日韩亚洲国产高清免费视频